INSP FY 2015 Earnings Report — Inspire Medical Systems, Inc. Revenue & Financial Results | Market Cap Arena

Inspire Medical Systems, Inc.INSP

FY 2015 Earnings

Reported December 30, 2015

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2015	Prior Q	FY 2014	QoQ Change	YoY Change
Revenue	$8M	—	—	—	—
Op. Income	-$20M	—	—	—	—
Gross Margin	64.9%	—	—	—	—
Net Margin	-266.3%	—	—	—	—
EPS (Diluted)	$-1.71	—	—	—	—
Free Cash Flow	-$23M	—	—	—	—

Income Statement

Item	Amount
REVENUE	$8M
Cost of Revenue	$3M
GROSS PROFIT	$5M
R&D Expenses	$7M
Selling & Marketing	$15M
General & Administrative	$3M
SG&A Expenses	$18M
Other Expenses	-$41.0K
Operating Expenses	$25M
Cost & Expenses	$28M
OPERATING INCOME	-$20M
Interest Income	$66.0K
Interest Expense	$2M
Other Income/Expenses	-$2M
INCOME BEFORE TAX	-$21M
Income Tax Expense	$0
Net Income from Continuing Ops	-$21M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	-$21M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	-$21M
D&A	$120.0K
EBIT	-$20M
EBITDA	-$20M
EPS	-$2
EPS Diluted	-$2

Cash Flow Statement

Item	Amount
Net Income	-$21M
Depreciation & Amortization	$120.0K
Stock-Based Compensation	$305.0K
Deferred Income Tax	$12.0K
Other Non-Cash Items	$50.0K
Change in Working Capital	-$1M
OPERATING CASH FLOW	-$22M
Capital Expenditure	-$346.0K
Acquisitions (Net)	$0
Purchases of Investments	$0
Sales/Maturities of Investments	$24M
Other Investing Activities	$24M
NET CASH FROM INVESTING	$24M
Net Debt Issuance	$3M
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	$0
NET CASH FROM FINANCING	$3M
FREE CASH FLOW	-$23M
Net Change in Cash	$4M